What we prioritize first Before focusing on GLP-1 dosing terminology, we prioritize the clinical fundamentals that have the strongest relevance to cognitive longevity: blood pressure optimization ApoB, LDL, triglyceride, and lipoprotein(a) risk assessment insulin resistance and glucose-pattern evaluation visceral fat and body-composition measurement resistance training and aerobic fitness sleep quality and sleep apnea evaluation when appropriate hearing and vision support nutrition quality and protein adequacy alcohol moderation inflammation and immune-metabolic context hormone evaluation when clinically indicated social connection, cognitive engagement, and meaningful activity None of these interventions is glamorous by itself
The glucagon receptor component is hypothesised to increase energy expenditure and promote fat breakdown (lipolysis), potentially offering additional weight loss benefits
GLP-1 Agonists and Athletic Performance: What We Know (and Don't Know) Research specific to endurance athletes and GLP-1 RAs is extremely limited
Heres how Rybelsus works, common side effects, cost considerations, and when you can potentially expect more GLP-1 oral medications to hit the market
The STEP 8 clinical trials found that once-weekly semaglutide 2.4 mg led to significantly greater weight loss than once-daily liraglutide 3.0 mg at 68 weeks in overweight adults without diabetes
Potency Accurate and verified active ingredient concentration to ensure consistent effectiveness in every batch